{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:34:19Z","timestamp":1792460059241,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Enamel Renal Syndrome (ERS) is a rare disorder characterized by a combination of dental and renal abnormalities, including stones and hypophosphatemia. ERS is genetically heterogeneous.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We report on four pediatric cases of homozygous LoF\n                      <jats:italic>FAM20A<\/jats:italic>\n                      mutations (2 families). Biological (including oral calcium load) and imaging (dental and renal) data were reviewed. Results are presented as median(range).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All patients were referred for renal screening by the specialized dental team at a median age of 14.5 [11\u201319] years. None of them presented symptoms of microscopic\/macroscopic hematuria, nor renal colic despite the presence of multiple bilateral nephrolithiasis in all and nephrocalcinosis in one family. Biological parameters were vastly similar, with preserved renal function (eGFR 109(93\u2013111) mL\/min\/1.73 m\u00b2), hypophosphatemia (median \u2212 1.9(-3.4;-1.7) SDS for age), elevated FGF-23 (98(84\u2013117) RU\/mL, normal range 21\u201391 RU\/mL) with hypocalciuria and low TmP\/GFR. Oral calcium load tests confirmed the absence of resorptive and absorptive hypercalciuria, with adequate PTH inhibition during the test; of note, \u201cbaseline\u201d PTH levels tended to be at the upper normal limit (83(65\u2013131) ng\/L, local upper normal limit 65ng\/L) that was not adequate in view of hypophosphatemia, with 25D levels at 44(19\u201392) nmol\/L. All patients were subsequently followed in pediatric nephrology and received hyperhydration and prudent vitamin D supplementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These cases highlight the need for interdisciplinary collaboration between pediatric nephrologists, dental specialists and geneticists, to ensure that patients receive timely renal evaluation. The identification of elevated FGF-23 levels in FAM20A-related ERS with severe nephrolithiasis and hypophosphatemia raises the question of the interest of burosumab as targeted therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04232-6","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T19:54:17Z","timestamp":1770321257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enamel renal syndrome due to FAM20A mutations: challenging kidney management in view of nephrocalcinosis, hypophosphatemia and hypocalciuria"],"prefix":"10.1186","volume":"21","author":[{"given":"Marie-Th\u00e9r\u00e8se","family":"Eid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"de Mul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Muresan-Vintila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Derain Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lia","family":"Bertholet-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Thivichon-Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0578-2529","authenticated-orcid":false,"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"11","key":"4232_CR1","doi-asserted-by":"publisher","first-page":"e250514","DOI":"10.1136\/bcr-2022-250514","volume":"15","author":"N Agrawal","year":"2022","unstructured":"Agrawal N, Awasthi A, Chakraborty PP, Maiti A. Hypoplastic amelogenesis imperfecta, bilateral nephrolithiasis and FGF-23-mediated hypophosphataemia: a triad of FAM20A-related enamel renal syndrome. BMJ Case Rep. 2022;15(11):e250514.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"4232_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.oooo.2016.09.226","volume":"123","author":"SPB P\u00eago","year":"2017","unstructured":"P\u00eago SPB, Coletta RD, Dumitriu S, Iancu D, Albanyan S, Kleta R, et al. Enamel-renal syndrome in 2 patients with a mutation in FAM20 A and atypical hypertrichosis and hearing loss phenotypes. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(2):229\u2013e2342.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"4232_CR3","first-page":"250","volume":"36","author":"M Ashkenazi","year":"2014","unstructured":"Ashkenazi M, Rafe Z, Sarnat H, Levin L. Nephrocalcinosis associated with continuous enamel hypoplasia and severe alveolar bone loss: a case report and literature review. Pediatr Dent. 2014;36(3):250\u20133.","journal-title":"Pediatr Dent"},{"issue":"1","key":"4232_CR4","first-page":"1","volume":"31","author":"MLM Farias","year":"2021","unstructured":"Farias MLM, Ornela GO, de Andrade RS, Martelli DRB, Dias VO, J\u00fanior HM. Enamel renal syndrome: A systematic review. Indian J Nephrol. 2021;31(1):1\u20138.","journal-title":"Indian J Nephrol"},{"key":"4232_CR5","doi-asserted-by":"publisher","first-page":"105008","DOI":"10.1016\/j.ejmg.2025.105008","volume":"75","author":"IA Roomaney","year":"2025","unstructured":"Roomaney IA, Kabbashi S, Chetty M. The craniofacial, dental and systemic manifestations of enamel renal syndrome: A scoping review. Eur J Med Genet. 2025;75:105008.","journal-title":"Eur J Med Genet"},{"issue":"4","key":"4232_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00247-022-05541-1","volume":"53","author":"J Bernardor","year":"2022","unstructured":"Bernardor J, Bidault V, Bacchetta J, Cabet S. Pediatric urolithiasis: what can pediatricians expect from radiologists? Pediatr Radiol. 2022;53(4):695\u2013705.","journal-title":"Pediatr Radiol"},{"issue":"6","key":"4232_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1177\/0300985812453177","volume":"49","author":"P Vogel","year":"2012","unstructured":"Vogel P, Hansen GM, Read RW, Vance RB, Thiel M, Liu J, et al. Amelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null mice. Vet Pathol. 2012;49(6):998\u20131017.","journal-title":"Vet Pathol"},{"issue":"11","key":"4232_CR8","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1002\/jcp.31105","volume":"238","author":"P Liu","year":"2023","unstructured":"Liu P, Li J, Tang L, Cong W, Jin H, Zhang H, et al. Mutations of family with sequence similarity 20-member C gene causing lethal and nonlethal raine syndrome causes hypophosphatemia rickets. J Cell Physiol. 2023;238(11):2556\u201369.","journal-title":"J Cell Physiol"},{"issue":"1","key":"4232_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12860-024-00526-4","volume":"26","author":"M Chen","year":"2025","unstructured":"Chen M, Sun D, Yee SP, Yuan Z, Lin L, Cui B, et al. Mutant Fam20c knock-in mice recapitulate both lethal and non-lethal human raine syndrome. BMC Mol Cell Biol. 2025;26(1):1.","journal-title":"BMC Mol Cell Biol"},{"key":"4232_CR10","doi-asserted-by":"crossref","unstructured":"Ohyama Y, Lin JH, Govitvattana N, Lin IP, Venkitapathi S, Alamoudi A, et al. FAM20A binds to and regulates FAM20C localization. Sci Rep. 2016 June;13:6:27784.","DOI":"10.1038\/srep27784"},{"key":"4232_CR11","doi-asserted-by":"publisher","first-page":"100267","DOI":"10.1016\/j.jbc.2021.100267","volume":"296","author":"CA Worby","year":"2021","unstructured":"Worby CA, Mayfield JE, Pollak AJ, Dixon JE, Banerjee S. The ABCs of the atypical Fam20 secretory pathway kinases. J Biol Chem. 2021;296:100267.","journal-title":"J Biol Chem"},{"issue":"21","key":"4232_CR12","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA, Boot AM, H\u00f6gler W, Linglart A, et al. Burosumab therapy in children with X-Linked hypophosphatemia. N Engl J Med. 2018;378(21):1987\u201398.","journal-title":"N Engl J Med"},{"issue":"5","key":"4232_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41581-024-00926-x","volume":"21","author":"D Haffner","year":"2025","unstructured":"Haffner D, Emma F, Seefried L, H\u00f6gler W, Javaid KM, Bockenhauer D, et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2025;21(5):330\u201354.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4232_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1834-7819.1972.tb02747.x","volume":"17","author":"D MacGibbon","year":"1972","unstructured":"MacGibbon D. Generalized enamel hypoplasia and renal dysfunction. Aust Dent J. 1972;17(1):61\u20133.","journal-title":"Aust Dent J"},{"issue":"2","key":"4232_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ajmg.1320200205","volume":"20","author":"M Lubinsky","year":"1985","unstructured":"Lubinsky M, Angle C, Marsh PW, Witkop CJ. Syndrome of amelogenesis imperfecta, nephrocalcinosis, impaired renal concentration, and possible abnormality of calcium metabolism. Am J Med Genet. 1985;20(2):233\u201343.","journal-title":"Am J Med Genet"},{"issue":"5","key":"4232_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1079-2104(05)80100-3","volume":"79","author":"RK Hall","year":"1995","unstructured":"Hall RK, Phakey P, Palamara J, McCredie DA. Amelogenesis imperfecta and nephrocalcinosis syndrome. Case studies of clinical features and ultrastructure of tooth enamel in two siblings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79(5):583\u201392.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"4232_CR17","doi-asserted-by":"crossref","unstructured":"Dellow EL, Harley KE, Unwin RJ, Wrong O, Winter GB, Parkins BJ. Amelogenesis imperfecta, nephrocalcinosis, and hypocalciuria syndrome in two siblings from a large family with consanguineous parents. Nephrol dial transplant off publ Eur dial transpl assoc -. Eur Ren Assoc. 1998;13(12):3193\u20136.","DOI":"10.1093\/ndt\/13.12.3193"},{"issue":"2","key":"4232_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.archoralbio.2004.11.023","volume":"50","author":"LM Paula","year":"2005","unstructured":"Paula LM, Melo NS, Silva Guerra EN, Mestrinho DH, Acevedo AC. Case report of a rare syndrome associating amelogenesis imperfecta and nephrocalcinosis in a consanguineous family. Arch Oral Biol. 2005;50(2):237\u201342.","journal-title":"Arch Oral Biol"},{"issue":"1\u20132","key":"4232_CR19","first-page":"1","volume":"122","author":"G Jaureguiberry","year":"2012","unstructured":"Jaureguiberry G, De la Dure-Molla M, Parry D, Quentric M, Himmerkus N, Koike T, et al. Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations. Nephron Physiol. 2012;122(1\u20132):1\u20136.","journal-title":"Nephron Physiol"},{"issue":"1","key":"4232_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.36187","volume":"164A","author":"PN Kantaputra","year":"2014","unstructured":"Kantaputra PN, Kaewgahya M, Khemaleelakul U, Dejkhamron P, Sutthimethakorn S, Thongboonkerd V, et al. Enamel-renal-gingival syndrome and FAM20A mutations. Am J Med Genet A. 2014;164A(1):1\u20139.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"4232_CR21","doi-asserted-by":"publisher","first-page":"e1003302","DOI":"10.1371\/journal.pgen.1003302","volume":"9","author":"SK Wang","year":"2013","unstructured":"Wang SK, Aref P, Hu Y, Milkovich RN, Simmer JP, El-Khateeb M, et al. FAM20A mutations can cause enamel-renal syndrome (ERS). PLoS Genet. 2013;9(2):e1003302.","journal-title":"PLoS Genet"},{"issue":"1","key":"4232_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/jisp.jisp_532_18","volume":"23","author":"K Debnath","year":"2019","unstructured":"Debnath K, Couthino A, Chatterjee A, Shenoy S. Enamel renal gingival syndrome: A rare case report. J Indian Soc Periodontol. 2019;23(1):69.","journal-title":"J Indian Soc Periodontol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04232-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04232-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04232-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:37:36Z","timestamp":1781631456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04232-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4232"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04232-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective series of cases was approved by the local ethical committee (\n                      Comit\u00e9 d\u2019Ethique des Hospices Civils de Lyon\n                      , AGORA 25-5073, session April 30th, 2025), and the work is in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JB has received speaker and research fees from Kyowa Kirin for projects around X-linked hypophosphatemia.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}